Top

Published in:

Open Access 01-12-2023 | Case report

Cerebellar metastasis of ovarian cancer: a case report

Authors: Eleonora Cabitza, Marta Pirola, Cinzia Baldessari, Giuditta Bernardelli, Elena Zunarelli, Stefania Pipitone, Maria Giuseppa Vitale, Cecilia Nasso, Eleonora Molinaro, Marco Oltrecolli, Elisa D’Agostino, Vincenzo Dario Mandato, Andrea Palicelli, Massimo Dominici, Roberto Sabbatini

Published in: Journal of Medical Case Reports | Issue 1/2023

Abstract

Background

Ovarian cancer is metastatic at presentation in about 62% of cases, but brain metastases are rare, reported in 3.3–4% of patients. Brain metastasis seems to be more frequent in advanced stages at diagnosis and in patients with BRCA1/2 mutation.

Case presentation

We present a case of a 47-year-old Caucasian woman, BRCA wild type, with an ovarian cancer that started with single cerebellar metastasis.

Conclusion

Brain metastases in ovarian cancer are rare and complex for diagnosis and management. This case focuses both on diagnosis and treatment, emphasizing the importance of a multimodal approach in a multidisciplinary team.

Jelovac D, Armstrong DK. Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin. 2011;61(3):183–203. https://doi.org/10.3322/caac.20113.CrossRefPubMedPubMedCentral

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. https://doi.org/10.3322/caac.21262.CrossRefPubMed

Rose PG, Piver MS, Tsukada Y, Lau TS. Metastatic patterns in hisologic variants of ovarian cancer. An autopsy study. Cancer. 1989;64(7):1508–13. https://doi.org/10.1002/1097-0142(19891001)64:7%3c1508:aid-cncr2820640725%3e3.0.co;2-v.CrossRefPubMed

Güth U, Huang DJ, Bauer G, Stieger M, Wight E, Singer G. Metastatic patterns at autopsy in patients with ovarian carcinoma. Cancer. 2007;110(6):1272–80. https://doi.org/10.1002/cncr.22919.CrossRefPubMed

Marchetti C, Ferrandina G, Cormio G, Gambino A, Cecere S, Lorusso D, et al. Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19). Gynecol Oncol. 2016;143:532–8. https://doi.org/10.1016/j.ygyno.2016.09.025.CrossRefPubMed

Geisler JP, Geisler HE. Brain metastases in epithelial ovarian carcinoma. Gynecol Oncol. 1995;57(2):246–9. https://doi.org/10.1006/gyno.1995.1134.CrossRefPubMed

Piura E, Piura B. Brain metastases from ovarian carcinoma. ISRN Oncol. 2011;2011: 527453. https://doi.org/10.5402/2011/527453. (Epub 2011 Dec 1).CrossRefPubMedPubMedCentral

Kolomainen DF, Larkin JM, Badran M, A’Hern RP, King DM, Fisher C, Bridges JE, Blake PR, Barton DP, Shepherd JH, Kaye SB, Gore ME. Epithelial ovarian cancer metastasizing to the brain: a late manifestation of the disease with an increasing incidence. J Clin Oncol. 2002;20(4):982–6. https://doi.org/10.1200/JCO.2002.20.4.982.CrossRefPubMed

Gardner AB, Charo LM, Mann AK, Kapp DS, Eskander RN, Chan JK. Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes. Clin Exp Metastasis. 2020;37(1):107–13. https://doi.org/10.1007/s10585-019-10007-0.CrossRefPubMed

10.

McMeekin DS, Kamelle SA, Vasilev SA, Tillmanns TD, Gould NS, Scribner DR, Gold MA, Guruswamy S, Mannel RS. Ovarian cancer metastatic to the brain: what is the optimal management? J Surg Oncol. 2001;78(3):194–200. https://doi.org/10.1002/jso.1149. (discussion 200-1).CrossRefPubMed

11.

Gourley C, Michie CO, Roxburgh P, Yap TA, Harden S, Paul J, Ragupathy K, Todd R, Petty R, Reed N, Hayward RL, Mitchell P, Rye T, Schellens JH, Lubinski J, Carmichael J, Kaye SB, Mackean M, Ferguson M. Increased incidence of visceral metastases in Scottish patients with BRCA1/2-defective ovarian cancer: an extension of the ovarian BRCAness phenotype. J Clin Oncol. 2010;28(15):2505–11. https://doi.org/10.1200/JCO.2009.25.1082. (Epub 2010 Apr 20).CrossRefPubMed

12.

Ratner E, Bala M, Louie-Gao M, Hazard S, Brastianos P. Brain metastases in primary ovarian cancer: real-world data. Ann Oncol. 2018;29(Suppl 8):viii332-358.

13.

Jernigan AM, Mahdi H, Rose PG. Epithelial ovarian cancer metastatic to the central nervous system and a family history concerning for hereditary breast and ovarian cancer–a potential relationship. Int J Gynecol Cancer. 2015;25(7):1232–8. https://doi.org/10.1097/IGC.0000000000000489.CrossRefPubMed

14.

Teckie S, Makker V, Tabar V, Alektiar K, Aghajanian C, Hensley M, Beal K. Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival. Radiat Oncol. 2013;15(8):36. https://doi.org/10.1186/1748-717X-8-36.CrossRef

15.

Deng K, Yang C, Tan Q, Song W, Lu M, Zhao W, Lou G, Li Z, Li K, Hou Y. Sites of distant metastases and overall survival in ovarian cancer: a study of 1481 patients. Gynecol Oncol. 2018;150(3):460–5. https://doi.org/10.1016/j.ygyno.2018.06.022. (Epub 2018 Jul 9).CrossRefPubMed

16.

Pectasides D, Pectasides M, Economopoulos T. Brain metastases from epithelial ovarian cancer: a review of the literature. Oncologist. 2006;11(3):252–60. https://doi.org/10.1634/theoncologist.11-3-252.CrossRefPubMed

17.

Anupol N, Ghamande S, Odunsi K, Driscoll D, Lele S. Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases. Gynecol Oncol. 2002;85(3):487–92. https://doi.org/10.1006/gyno.2002.6653.CrossRefPubMed

18.

Cormio G, Loizzi V, Falagario M, Lissoni AA, Resta L, Selvaggi LE. Changes in the management and outcome of central nervous system involvement from ovarian cancer since 1994. Int J Gynaecol Obstet. 2011;114(2):133–6. https://doi.org/10.1016/j.ijgo.2011.02.014. (Epub 2011 Jun 12).CrossRefPubMed

19.

Growdon WB, Lopez-Varela E, Littell R, Oliva E, Seiden M, Krasner C, Lee H, Fuller A. Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer. Int J Gynecol Cancer. 2008;18(2):262–8. https://doi.org/10.1111/j.1525-1438.2007.01011.x. (Epub 2007 Jun 22).CrossRefPubMed

20.

Mikule K, Wilcoxen K. The PARP inhibitor, niraparib, crosses the blood brain barrier in rodents and is efficacious in a BRCA2-mutant intracranial tumor model [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2015 Nov 5–9; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2015;14(12 Suppl 2):Abstract nr B168_.

21.

Gray S, Khor XY, Yiannakis D. Niraparib as maintenance therapy in a patient with ovarian cancer and brain metastases. BMJ Case Rep. 2019;12(8): e230738. https://doi.org/10.1136/bcr-2019-230738.CrossRefPubMedPubMedCentral

Title: Cerebellar metastasis of ovarian cancer: a case report
Authors: Eleonora Cabitza
Marta Pirola
Cinzia Baldessari
Giuditta Bernardelli
Elena Zunarelli
Stefania Pipitone
Maria Giuseppa Vitale
Cecilia Nasso
Eleonora Molinaro
Marco Oltrecolli
Elisa D’Agostino
Vincenzo Dario Mandato
Andrea Palicelli
Massimo Dominici
Roberto Sabbatini
Publication date: 01-12-2023
Publisher: BioMed Central
Published in: Journal of Medical Case Reports / Issue 1/2023
Electronic ISSN: 1752-1947
DOI: https://doi.org/10.1186/s13256-023-04211-6

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Cerebellar metastasis of ovarian cancer: a case report

Abstract

Background

Case presentation

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Case presentation

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2023

Personalized medicine: paradigm shift in ALK positive non-small cell lung cancer: a case report

Spontaneous retroperitoneal hematoma: a case report

Slittable sheath supported right ventricular pacing lead implantation in persistent left superior vena cava with absent right superior vena cava: a case report

Fluorouracil-induced leukoencephalopathy mimicking neuroleptic malignant syndrome: a case report

Severe lumbar pain in an adolescent due to idiopathic vena cava thrombosis: a case report

Internal carotid artery aneurysm with incomplete isolated oculomotor nerve palsy: a case report